A Therapeutic Equivalence Study of Ketoconazole Cream 2%

Status Completed

Clinical Trial Summary

Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis.

Clinical Trial Description

A randomized, double-blind, vehicle-controlled, parallel-design, multiple-site study to evaluate the clinical (therapeutic) effet of a generic Ketoconazole Cream 2% (Douglas Pharmaceuticals America Ltd) compared with the reference standard Ketoconazole Cream 2% (Teva Pharmaceuticals USA Inc) in subjects with a microbiologically-confirmed, clinical diagnosis of tinea pedis. Approximately 675 subjects, male or female, 18 years or older, will be enrolled. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04203342
Study type	Interventional
Source	Douglas Pharmaceuticals America Ltd
Contact
Status	Completed
Phase	Phase 3
Start date	December 11, 2019
Completion date	July 13, 2020

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05493488` - A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis	Phase 2
Completed	`NCT04883593` - A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.	Early Phase 1
Terminated	`NCT02842021` - Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis	Phase 2
Completed	`NCT01712360` - Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis	Phase 4
Completed	`NCT00781664` - Cumulative Irritation Test	Phase 1
Completed	`NCT03676686` - Study With Nåva Foot Cream in Patients With Tinea Pedis Interdigitalis	N/A
Completed	`NCT01519752` - A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis	Phase 1
Completed	`NCT03320486` - Non-inferiority Trial of Dapaconazole Versus Ketoconazole	Phase 3
Completed	`NCT01580891` - Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis	Phase 1
Completed	`NCT01353976` - Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis	Phase 3
Completed	`NCT01349998` - Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis	Phase 3
Completed	`NCT04265521` - Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet	N/A
Completed	`NCT02633813` - BE Study of Naftifine HCL	Phase 3
Recruiting	`NCT00856596` - Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females	Phase 3
Completed	`NCT00869336` - Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)	Phase 2
Completed	`NCT00768599` - A Study of Econazole Foam 1% in Athlete's Foot	Phase 2
Recruiting	`NCT00233493` - Spread of Dermatophytes Among Families	N/A
Completed	`NCT03897257` - A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis	Phase 2
Completed	`NCT03129321` - Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis	Phase 3
Completed	`NCT02335255` - Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis	Phase 1